145 related articles for article (PubMed ID: 38200187)
1. Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based study.
Guo Y; Chen H; Wan J; Ren Y; Wu F; Chen L; Sun T; Yang L; Zheng C
Sci Rep; 2024 Jan; 14(1):1030. PubMed ID: 38200187
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study.
Chen L; Sun T; Chen S; Ren Y; Yang F; Zheng C
World J Surg Oncol; 2020 Jun; 18(1):119. PubMed ID: 32487104
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of pre-surgery and post-surgery radiotherapy in the treatment of hepatocellular carcinoma: a population-based study.
Chen L; Guo X; Chen S; Ren Y; Sun T; Yang F; Zheng C
Am J Transl Res; 2021; 13(1):360-371. PubMed ID: 33527030
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based study.
Chen L; Ren Y; Sun T; Cao Y; Yan L; Zhang W; Ouyang T; Zheng C
Cancer Med; 2021 Jun; 10(11):3715-3725. PubMed ID: 33960697
[TBL] [Abstract][Full Text] [Related]
5. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
[No Abstract] [Full Text] [Related]
6. Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma.
Han B; Shao L; Li C; Xu Y; Tang Y; Han L; Qi X
J BUON; 2019; 24(4):1390-1401. PubMed ID: 31646782
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ Metastasis.
Chen L; Wang Z; Song S; Sun T; Ren Y; Zhang W; Wang M; Liu Y; Zheng C
J Oncol; 2021; 2021():5190611. PubMed ID: 34840570
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
10. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database.
Lin Q; Huang X; Zhong C; Luo T; Zeng X; Chen S
Cancer Med; 2019 Feb; 8(2):515-526. PubMed ID: 30656831
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm.
Yang P; Li N
J Int Med Res; 2022 Jul; 50(7):3000605221111281. PubMed ID: 35861264
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
Hara K; Takeda A; Tsurugai Y; Saigusa Y; Sanuki N; Eriguchi T; Maeda S; Tanaka K; Numata K
Hepatology; 2019 Jun; 69(6):2533-2545. PubMed ID: 30805950
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Surgical Resection versus Radiofrequency Ablation for the Treatment of Single Hepatocellular Carcinoma: A SEER-Based Study.
Wu F; Wei C; Zhang S; Jia S; Zhang J
Gastroenterol Res Pract; 2023; 2023():1269504. PubMed ID: 36865983
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database.
Qiu X; Cai J; Chen H; Yao J; Xiao C; Li R; Xiao J; Zhang J; Sui X; Lu T; Zheng J; Zhang Y; Yang Y
Front Oncol; 2023; 13():1098686. PubMed ID: 37409255
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
[TBL] [Abstract][Full Text] [Related]
20. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]